MedTrace Logo

Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)

NCT03028324 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2020-05-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the influence of transcranial magnetic stimulation (TMS) on speech performance in individuals with primary progressive apraxia of speech.

Conditions

  • Apraxia Speech

Interventions

DEVICE

Transcranial Magnetic Stimulation (TMS)

Non-invasive brain stimulation, high frequency repetitive TMS delivered in 10 sessions over a 2-week period.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Joyce R Gomes Osman, PT, PhD · Univeristy of Miami Miller School of Medicine

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-09
Primary Completion
2018-11-13
Completion
2018-11-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028324 on ClinicalTrials.gov